Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups

Microsatellite Stable Colorectal Cancers Stratified by the BRAF V600E Mutation Show Distinct Patterns of Chromosomal Instability

(2014) Catherine E. Bond et al.   PLoS One

Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma

(2014) Shuang-Xiang Tan et al.   TUMOR BIOLOGY

The CIMP Phenotype inBRAFMutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort

(2014) Winnie C. Fernando et al.   Gastroenterology Research and Practice

Long noncoding RNAs and the genetics of cancer

(2013) S W Cheetham et al.   BRITISH JOURNAL OF CANCER

Genomic Aberrations Occurring in Subsets of Serrated Colorectal Lesions but not Conventional Adenomas

(2013) A. N. Burnett-Hartman et al.   CANCER RESEARCH

Interplay between the Cancer Genome and Epigenome

(2013) Hui Shen et al.   CELL

Prdm5 suppresses ApcMin-driven intestinal adenomas and regulates monoacylglycerol lipase expression

(2013) G G Galli et al.   ONCOGENE

Recurrent R-spondin fusions in colon cancer

(2012) Somasekar Seshagiri et al.   NATURE

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Characteristics of Advanced- and Non Advanced Sporadic Polypoid Colorectal Adenomas: Correlation to KRAS Mutations

(2012) Enkh-Amar Yadamsuren et al.   PATHOLOGY & ONCOLOGY RESEARCH

Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers

(2012) Catherine E. Bond et al.   PLoS One

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Prdm5 Regulates Collagen Gene Transcription by Association with RNA Polymerase II in Developing Bone

(2012) Giorgio Giacomo Galli et al.   PLoS Genetics

Mutations in PRDM5 in Brittle Cornea Syndrome Identify a Pathway Regulating Extracellular Matrix Development and Maintenance

(2011) Emma M.M. Burkitt Wright et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Intermediate Methylation Epigenotype and Its Correlation to KRAS Mutation in Conventional Colorectal Adenoma

(2011) Koichi Yagi et al.   AMERICAN JOURNAL OF PATHOLOGY

Promoter methylation of Wnt antagonistsDKK1andSFRP1is associated with opposing tumor subtypes in two large populations of colorectal cancer patients

(2011) James B. Rawson et al.   CARCINOGENESIS

Oncogenic PIK3CA mutations in colorectal cancers and polyps

(2011) Vicki L.J. Whitehall et al.   INTERNATIONAL JOURNAL OF CANCER

p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers

(2011) Catherine E. Bond et al.   INTERNATIONAL JOURNAL OF CANCER

The Epigenetic Modifier PRDM5 Functions as a Tumor Suppressor through Modulating WNT/β-Catenin Signaling and Is Frequently Silenced in Multiple Tumors

(2011) Xing-sheng Shu et al.   PLoS One

Role of the Serrated Pathway in Colorectal Cancer Pathogenesis

(2010) Barbara Leggett et al.   GASTROENTEROLOGY

DNA methylation and carcinogenesis of PRDM5 in cervical cancer

(2010) Hai-Yan Cheng et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The Tumor Suppressor PRDM5 Regulates Wnt Signaling at Early Stages of Zebrafish Development

(2009) Natalia Meani et al.   PLoS One

CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component

(2007) Sanjay Kakar et al.   HUMAN PATHOLOGY